Tempus AI (TEM) reported a Q4 non-GAAP net loss late Monday of $0.18 per diluted share.
Analysts polled by FactSet expected a loss of $0.16.
Revenue for the quarter ended Dec. 31 was $200.7 million, up from $147.7 million a year earlier.
Analysts surveyed by FactSet expected $203.1 million.
The company said it expects full year 2025 revenue of roughly $1.24 billion, including Ambry Genetics. Analysts expected sales of $896.3 million, if comparable.
Shares of the company were down more than 10% in after-hours trading.